NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 75 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 443.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $286,618 | -83.6% | 159,232 | -80.7% | 0.28% | -75.8% |
Q3 2022 | $1,747,000 | -39.9% | 823,974 | -23.7% | 1.15% | -56.5% |
Q2 2022 | $2,907,000 | -38.0% | 1,080,566 | 0.0% | 2.65% | -23.8% |
Q1 2022 | $4,690,000 | -26.1% | 1,080,566 | -11.8% | 3.48% | +56.7% |
Q4 2021 | $6,346,000 | -31.1% | 1,225,060 | -18.3% | 2.22% | -18.1% |
Q3 2021 | $9,210,000 | -39.2% | 1,500,000 | 0.0% | 2.71% | -28.1% |
Q2 2021 | $15,150,000 | – | 1,500,000 | – | 3.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrona Venture Group, LLC | 6,020,770 | $30,663,000 | 4.08% |
Ally Bridge Group (NY) LLC | 1,500,000 | $9,210,000 | 2.71% |
AMAZON COM INC | 1,457,055 | $8,946,000 | 1.82% |
Affinity Asset Advisors, LLC | 975,000 | $5,987,000 | 1.51% |
Tikvah Management LLC | 708,540 | $4,350,436,000 | 1.18% |
Perceptive Advisors | 8,911,151 | $54,714,000 | 0.80% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $12,280,000 | 0.76% |
HILLMAN CO | 200,000 | $1,228,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,912,000 | 0.41% |
RA Capital Management | 2,436,430 | $14,960,000 | 0.21% |